PERSPECTIVES OF THERAPY WITH CEREBROLYSIN IN NEUROLOGY AND ITS PLACE IN CLINICAL PRACTICE OF PEDIATRIC NEUROLOGY
https://doi.org/10.17650/2073-8803-2012-7-3-27-40
- Р Р‡.МессенРТвЂВжер
- РћРТвЂВнокласснРСвЂВРєРСвЂВ
- LiveJournal
- Telegram
- ВКонтакте
- РЎРєРѕРїРСвЂВровать ссылку
Full Text:
Abstract
A detailed review of the literature, reflecting many aspects of сerebrolysin in a wide range of nervous system disorders, including various diseases in children is described. In addition to high efficacy, the therapy was well tolerated, which further enhances the perspectives of using сerebrolysin in pediatric neurology
About the Authors
A. S. Petrukhin
Кафедра неврологии, нейрохирургии и медицинской генетики лечебного факультета ГБОУ ВПО РНИМУ им. Н.И. Пирогова;
Президент НП «Объединение врачей-эпилептологов и пациентов», Москва
Russian Federation
Russian Federation
O. A. Pylaeva
Институт детской неврологии и эпилепсии им. Святителя Луки, Москва
Russian Federation
Russian Federation
References
1. Grebennikova O.V., Degtyareva M.G., Medvedev M.I., Rogatkin S.O. «Vliyanie terapii preparatom, soderzhashchim nizkomolekulyarnye biologicheski aktivnye neiropeptidy, na spektral'nye kharakteristiki EEG spokoinogo sna u nedonoshennykh detei s perinatal'nymi gipoksicheski-ishemicheskimi porazheniyami TsNS» //«Voprosy prakticheskoi pediatrii». --2008. - t. 3. - -№. 5 - S. 19.
2. Grebennikova O.V., Degtyareva M.G., Rogatkin S.O., Medvedev M.I.. «Vliyanie «Tserebrolizina» na formirovanie EEG-patterna sna u nedonoshennykh detei s perinatal'nymi gipoksicheski-ishemicheskimi porazheniyami TsNS» //«Voprosy prakticheskoi pediatrii». - 2007. - t. 2. - №. 5 - S.16.
3. Gusev E.I., Burd G.S., Gekht A.B., Skvortsova V.I., Bogomolova M.A., Selikhova M.V. Kliniko-neiropsikhologicheskoe issledovanie Tserebrolizina // Zhurn. nevrol psikhiatr. - 1994. - 94(1). - 9-13.
4. Zavadenko N.N. Giperaktivnost' i defitsit vnimaniya v detskom vozraste. - M., 2005. - 256 s.
5. Zavadenko N.N., Suvorinova N.Yu., Grigor'eva N.V. Giperaktivnost' s defitsitom vnimaniya u detei: sovremennye podkhody k farmakoterapii // Psikhiatriya i psikhofarmakoterapiya. - 2000. - T. 2, №2.
6. Zavadenko N.N., Suvorinova N.Yu., Rumyantseva M.V., Petrukhin A.S. Tserebrolizin v lechenii minimal'nykh mozgovykh disfunktsii u detei IV . Mezhdunarodnyi Simpozium «Tserebrolizin: farmakologicheskie effekty i mesto v klinicheskoi praktike». - M., 2002. - S, 66-79,
7. Zykov V.P., Novikova E.B., Shvabrina T.V. Tserebrolizin v lechenii tikoznykh giperkinezov u detei // RMZh. - 2012. - № 33.
8. Iznak A.F., Iznak E.V., Zavadenko N.N., Guzilova L.S. Neirofiziologicheskie pokazateli plastichnosti TsNS v dinamike terapii posledstvii cherepno-mozgovoi travmy u podrostkov // Fiziologiya cheloveka
9. Iznak E. V., Iznak A. F., Pankratova E. A., Zavadenko N.N., Guzilova L. S. Guzilova Yu. I. Elektrofiziologicheskie korrelyaty effektivnosti nootropnoi terapii posledstvii cherepno-mozgovoi travmy u podrostkov // Zhurn nevrol psikhiatr. - 2010. - № 5. - S. 27-32.
10. Kemalov A.I., Zavadenko N.N., Petrukhin A.S., Musaparbekova A.Zh. Otsenka effektivnosti tserebrolizina pri lechenii posledstvii zakrytoi cherepno-mozgovoi travmy u detei// Tserebrolizin: farmakologicheskie effekty i mesto v khirurgicheskoi praktike. - M., 2002. - S. 80-89.
11. Medvedev M.I., Rogatkin S.O., Gorbunov A.V., Degtyareva M.G., Grebennikova O.V., Potapova O.V., Morozova E.N. Optimizatsiya lecheniya perinatal'nykh gipoksicheski-ishemicheskikh porazhenii golovnogo mozga u nedonoshennykh detei // Zhurnal «Trudnyi patsient». - 2009. - № 8-9.
12. Medvedev M.I., Rogatkin S.O., Grebennikova O.V., Degtyareva M.G., Gorbunov A.V., Potapova O.V., Morozova E.N., Mileva O.I. «Primenenie «Tserebrolizina» v terapii gipoksicheski-ishemicheskikh porazhenii TsNS u nedonoshennykh detei» //«Voprosy prakticheskoi pediatrii». - 2007. - t. 2. - №. 5. - S. 27.
13. Serkina E.V., Gromova O.A., Torshin I.Yu., Sotnikova N.Yu., Nikonov A.A. Tserebrolizin oblegchaet sostoyanie bol'nykh s perinatal'nym porazheniem TsNS cherez modulyatsiyu autoimmuniteta i antioksidantnuyu zashchitu // Zhurnal nevrologii i psikhiatrii. - 2008. T. 108. - № 11.- S. 62-66.
14. Skvortsova V.I. i soavt. Rezul'taty mnogotsentrovogo issledovaniya bezopasnosti i effektivnosti Tserebrolizina u bol'nykh s ishemicheskim insul'tom // Zhurn. nevrol. psikhiatr. - 2006. - vyp.16, «Insul't» prilozhenie k zhurnalu. - S. 41-45.
15. Skvortsova V.I. i soavt. Randomizirovannoe dvoinoe slepoe platsebo-kontroliruemoe issledovanie bezopasnosti i effektivnosti tserebrolizina v lechenii ostrogo ishemicheskogo insul'ta // Zhurn.nevrol. psikhiatr. - 2004. - vyp.11, «Insul't» prilozhenie k zhurnalu. - S. 51-5.
16. Allegri R.F., Guekht A. Cerebrolysin Improves Symptoms And Delays Progression In Patients With Alzheimer's Disease And Vascular Dementia // Drugs of Today. - 2012. - V. 48(Supplement A). - P. 25-41.
17. Alvarez X.A., Cacabelos R., Sampedro C., Couceiro V., Aleixandre M., Vargas M., Linares C., Granizo E., Garcia-Fantini M., Baurecht W., Doppler E., Moessler H. Combination treatment in Alzheimer's disease: results of a randomized, controlled trial withcerebrolysin and donepezil // Curr Alzheimer Res. - 2011. - V. 8(5). - P. 583-91.
18. Alvarez X.A., et al. A 24-week, double-blind, placebo-controlled study of three dosages of Cerebrolysin in patients with mild to moderate Alzheimer's disease // Eur J Neurol. - 2006. - V. 13(1). - P. 43-54.
19. Bornstein N., Poon W.S. Accelerated recovery from acute brain injuries: clinical efficacy of neurotrophic treatment in stroke and traumatic brain injuries // Drugs Today (Barc). - 2012. - V. 48 Suppl A. - P. 43-61.
20. Bajenaru O., Tiu C., Moessler H., Antochi F., Muresanu D., Popescu B.O., Novak P. Efficacy and safety of Cerebrolysin in patients with hemorrhagic stroke // J Med Life. - 2010. - V. 3(2). - P. 137-143.
21. Gershman R.N., Vasilenko M.A. Use of cerebrolysin and ATP in treating infantile cerebral paralysis // Pediatr Akus Ginekol. - 1975 Jan-Feb;(1). - P. 22-3.
22. Gheht A.B., Moessler H., Novak P.H., Gusev E. I. on behalf of the Cerebrolysin Investigators. Cerebrolysin in Vascular Dementia: Improvement of Clinical Outcome in Randomized, Double-Blind, Placebo-Controlled Multicenter Trial // Journal of Stroke and Cerebrovascular Diseases. - 2010. - V. 20(4). - P. 310-8.
23. Guseva M.R. Neuropeptides in the treatment of optic nerve atrophy in children // Zh Nevrol Psikhiatr Im S S Korsakova. - 2010. - V. 110(4). - P. 37-40.
24. Haffner Z., Javor L., Windisch M., Gmeinbauer R. Cerebrolysin in acute ischemic stroke. 31st International Danube Symposium for Neurological Sciences and Continuing Education. - Szeged, Hungary, 1999.
25. Haffner Z. Efficacy of Cerebrolysin in patients with acute ischaemic stroke. Final Study Report. - 2000. - 1-34.
26. Haffner Z., Javor L., Windisch M., Gmeinbauer R. Cerebrolysin in acute stroke // Cephallag Hungr. - 1999. - P. 52-53.
27. Heiss W.D., et al. Cerebrolysin in Patients With Acute Ischemic Stroke in Asia. Results of a Double-Blind, Placebo-Controlled Randomized Trial // Stroke. - 2012. - V. 43 (3). - P. 630-6.
28. Herrschaft H. Wirksamkeit von Cerebrolysin bei akutem ischamischen Hirninfarct. Integrierter klinischer Studienbericht. - 1998. - P. 1-74.
29. Koppi S., Barolin G.S. Hemodilution therapy with neuron metabolism specific therapy in ischemic stroke-encouraging results of a comparative study // Wien Med Wochenschr. - 1996. - V. 146(3). - P. 41-8.
30. Ladurner G., et al. Neuroprotective treatment with Cerebrolysin in patients with acute stroke: a randomized controlled trial //J Neural Transm. - 2005. - V. 112. - P. 415-428.
31. Masliah E., Diez-Tejedor E. The pharmacology of neurotrophic treatment with Cerebrolysin: brain protection and repair to counteract pathologies of acute and chronic neurological disorders // Drugs Today (Barc). - 2012. - V. 48 Suppl A. - P. 3-24.
32. Muresanu D., et al. Cerebrolysin and recovery after stroke (CARS): A randomized, placebo-controlled, double-blind, multicenter, phase II clinical study. Clinical Study Report, May 2011
33. Muresanu D.F., Alvarez X.A., Moessler H., Novak P.H., Stan A., Buzoianu A., Bajenaru O., Popescu B.O. Persistence of the effects of Cerebrolysin on cognition and qEEG slowing in vascular dementia patients: results of a 3-month extension study // J Neurol Sci. - 2010. - V. 299(1-2). - P. 179-83.
34. Panisset M. Cerebrolysin in Alzheimer’s disease: a randomized, double-blind, placebo-controlled trial with a neurotrophic agent // J Neural Transm. - 2002. - V. 109- P. 1089-1104.
35. Radzivil M.G., Bashina V.M. An effect of long-term cerebrolysin therapy in combination with neuroleptics on behavioral and cognitive disturbances in endogenous childhood autism // Zh Nevrol Psikhiatr Im S S Korsakova. - 2006. - V. 106(2). - P. 21-5.
36. Rockenstein E., Ubhi K., Pham E., Michael S., Doppler E., Novak P., Inglis C., Mante M., Adame A., Alvarez X.A., Moessler H., Masliah E. Beneficial effects of a neurotrophic peptidergic mixture persist for a prolonged period following treatment interruption in a transgenic model of Alzheimer's disease // J Neurosci Res. - 2011. - V. 89(11). - P. 1812-21.
37. Ruether E., Alvarez X.A., Rainer M., Moessler H. Sustained improvement of cognition and global function in patients with moderately severe Alzheimer's disease: a double-blind, placebo-controlled study with the neurotrophic agent Cerebrolysin // J Neural Transm Suppl. - 2002. - V. 62. - P. 265-75.
38. Ruether E., Husmann R., Kinzler E., Diabl E., Klingler D., Spatt J., Ritter R., Schmidt R., Taneri Z., Winterer W., Koper D., Kasper S., Rainer M., Moessler H. A 28-week, double-blind, placebo-controlled study with Cerebrolysin in patients with mild to moderate Alzheimer's disease // Int Clin Psychopharmacol. - 2001. - V. 16(5). - P. 253-63.
39. Shi Y., Ding S., Deng B., Wang Q. Clinical studies with Cerebrolysin in the treatment of acute cerebral hemorrhage. Chinese Journal of Nervous and Mental Diseases. - 1990. - V. 16/4. - P.228-230.
Review
For citations:
Petrukhin A.S., Pylaeva O.A. PERSPECTIVES OF THERAPY WITH CEREBROLYSIN IN NEUROLOGY AND ITS PLACE IN CLINICAL PRACTICE OF PEDIATRIC NEUROLOGY. Russian Journal of Child Neurology. 2012;7(3):27-40. (In Russ.) https://doi.org/10.17650/2073-8803-2012-7-3-27-40
Views:
1306
© A. S. Petrukhin, O. A. Pylaeva, 2015
ISSN 2073-8803 (Print)
ISSN 2412-9178 (Online)
ISSN 2412-9178 (Online)
Email this article 